148 related articles for article (PubMed ID: 38546389)
1. Identification of a novel disulfideptosis-related gene signature for prognostic implication in lower-grade gliomas.
Zhang F; Lv M; He Y
Aging (Albany NY); 2024 Mar; 16(7):6054-6067. PubMed ID: 38546389
[TBL] [Abstract][Full Text] [Related]
2. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
3. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
6. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
7. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB
J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759
[TBL] [Abstract][Full Text] [Related]
9. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
Chen J; Li Y; Han X; Pan Y; Qian X
Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
[TBL] [Abstract][Full Text] [Related]
10. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
11. EPHB2 as a key mediator of glioma progression: Insights from microenvironmental receptor ligand-related prognostic gene signature.
Tan L; Zhou J; Nie Z; Li D; Wang B
Genomics; 2024 May; 116(3):110799. PubMed ID: 38286348
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
[TBL] [Abstract][Full Text] [Related]
15. Classifying lower grade glioma cases according to whole genome gene expression.
Chen B; Liang T; Yang P; Wang H; Liu Y; Yang F; You G
Oncotarget; 2016 Nov; 7(45):74031-74042. PubMed ID: 27677590
[TBL] [Abstract][Full Text] [Related]
16. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
Li X; Deng X; Liu T; Zhang W; Tao J
Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
[TBL] [Abstract][Full Text] [Related]
17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
18. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
[TBL] [Abstract][Full Text] [Related]
19. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.
Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y
Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964
[TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes related to prognosis in glioma.
Zhang D; Zhao J; Han C; Liu X; Liu J; Yang H
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]